EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Therapeutic Targeting of Oxidative Stress in Hematopoietic Stem Cells: Current Strategies and Future Directions

Dharmaraj Senthilkumar, Sathish Kumar Venkatachalam, Nallusamy Duraisamy, Zaw Myo Hein, Vasudevan Ramachandran, Suresh Kumar, Muhammad Danial Che Ramli, Anastasiya Spaska

Stem Cells International · 2026-01 · 2026 (1)

DOI: 10.1155/sci/9975574 ↗
AbstractBibliografische Angaben

Abstract

The maintenance of blood homeostasis relies heavily on hematopoietic stem cells (HSC), whose function is highly sensitive to oxidative stress caused by disrupted equilibrium between reactive oxygen species (ROS) and antioxidant systems. This review provides a comprehensive examination of the current strategies aimed at therapeutically targeting oxidative stress in HSC, outlining both the challenges and the advancements in this domain. We discuss the intricate mechanisms by which oxidative stress disrupts HSC self‐renewal, quiescence, and differentiation, as well as the implications for aging and hematological malignancies. The function of the hypoxic bone marrow microenvironment in reducing oxidative damage is highlighted alongside the metabolic adaptations that support HSC viability. Furthermore, we explore emerging therapeutic approaches, including antioxidants, gene editing technologies, and niche modulation, that aim to enhance HSC function and resilience in the face of oxidative stress. Drawing on recent preclinical and clinical findings, this review highlights the need for novel strategies that integrate a deeper understanding of redox biology with therapeutic interventions to enhance outcomes in HSC transplantation and regeneration. This integration of current findings and emerging strategies provides valuable insights for developing targeted therapies aimed at preserving HSC integrity in the treatment of hematologic diseases.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →